Company Comparison
Tango Therapeutics vs 54gene
Side-by-side comparison of two portfolio companies — sector, funding stage, investors, valuation, and more.
| Metric | Tango Therapeutics | 54gene |
|---|---|---|
| Sector | Biotech | Biotech |
| Headquarters | — | Lagos, Nigeria |
| Founded | — | 2019 |
| Status | Active | Active |
| Last Funding Stage | — | Series B |
| Total Funding | — | $45M |
| Valuation | — | — |
What They Build
Tango Therapeutics
Tango Therapeutics develops precision oncology medicines using synthetic lethality approaches to target cancer vulnerabilities created by tumor suppressor gene loss.
54gene
African genomics research company advancing precision medicine through genetic research focused on African populations.
Key Investors
Tango Therapeutics
Sector Overlap
Both Tango Therapeutics and 54gene operate in Biotech.
Browse all Biotech companies →